Transient rise in CA 125 in a woman with ovarian carcinoma and COVID-19 infection
Cancer antigen 125 (CA 125) is a transmembrane glycoprotein expressed on the surface of germinal epithelium and other tissues derived from embryonic coelomic epithelium (Bischof, 1993). CA 125 is a useful biomarker to detect treatment response and recurrence of ovarian malignancy (Montagnana et al.,...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/13565
- Acceso en línea:
- https://doi.org/10.1016/j.gore.2020.100644
http://hdl.handle.net/20.500.12010/13565
- Palabra clave:
- CA 125
COVID-19
Infection
Ovarian carcinoma
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)